Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use within the pharmaceutical and biotechnology industry primarily in the United Kingdom and Malaysia. The company provides EpiSwitch, a proprietary technology platform for the discovery, evaluation, validation, and monitoring of epigenetic biomarkers known as chromosome conformation signatures. It has collaboration agreements with Holos Life Sciences Pte. Ltd. to develop non-invasive epigenetic biomarkers associated with sports-related concussions; and Casa Sollievo della Sofferenza to identify EpiSwitch biomarkers for the blood-based diagnosis of Autism Spectrum Disorder. The company was founded in 2007 and is headquartered in Oxford, the United Kingdom.
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+44-1865-518910
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales£1.19 million
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Oxford Biodynamics (LON:OBD) Frequently Asked Questions
What is Oxford Biodynamics' stock symbol?
Oxford Biodynamics trades on the London Stock Exchange (LON) under the ticker symbol "OBD."
How were Oxford Biodynamics' earnings last quarter?
Oxford Biodynamics PLC (LON:OBD) released its quarterly earnings data on Tuesday, December, 11th. The biotechnology company reported ($2.20) earnings per share for the quarter. View Oxford Biodynamics' Earnings History.
Has Oxford Biodynamics been receiving favorable news coverage?
News stories about OBD stock have trended somewhat positive on Tuesday, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Oxford Biodynamics earned a news sentiment score of 0.8 on InfoTrie's scale. They also assigned headlines about the biotechnology company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the near future.
Who are some of Oxford Biodynamics' key competitors?
Some companies that are related to Oxford Biodynamics include Theratechnologies (TH), Biotest (BIO), Polynovo (PNV), Oxford BioMedica (OXB), Senesco Technologies (ELOX), Stemline Therapeutics (STML), Starpharma (SPL), Neptune Wellness Solutions (NEPT), IMV (IMV), Enochian Biosciences (ENOB), Monash IVF Group (MVF), Kodiak Sciences (KOD), Horizon Discovery Group (HZD), Verastem (VSTM) and Emblem (EMC).
What other stocks do shareholders of Oxford Biodynamics own?
Who are Oxford Biodynamics' key executives?
Oxford Biodynamics' management team includes the folowing people:
- Mr. Christian Gurth Hoyer Millar, CEO & Director (Age 60)
- Mr. Paul Leslie Stockdale, CFO & Director (Age 44)
- Dr. Alexandre Akoulitchev, Chief Scientific Officer & Director (Age 57)
- Dr. Aroul Ramadass Ph.D.(CANTAB), PDF (OXON), FCPS, FRAS, Chief Technology Officer
- Mr. Martin Reeves, Sr. VP of Commercial Devel.
How do I buy shares of Oxford Biodynamics?
Shares of OBD and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Oxford Biodynamics' stock price today?
One share of OBD stock can currently be purchased for approximately GBX 151.
How big of a company is Oxford Biodynamics?
Oxford Biodynamics has a market capitalization of £139.77 million and generates £1.19 million in revenue each year.
What is Oxford Biodynamics' official website?
How can I contact Oxford Biodynamics?
Oxford Biodynamics' mailing address is 26 Beaumont Street, OXFORD, OX1 2NP, United Kingdom. The biotechnology company can be reached via phone at +44-1865-518910.
MarketBeat Community Rating for Oxford Biodynamics (LON OBD)
MarketBeat's community ratings are surveys of what our community members think about Oxford Biodynamics and other stocks. Vote "Outperform" if you believe OBD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OBD will underperform the S&P 500 over the long term. You may vote once every thirty days.
